CORC

浏览/检索结果: 共70条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:46/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:36/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:38/0  |  提交时间:2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载:32/0  |  提交时间:2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载:30/0  |  提交时间:2019/12/05
A Novel Bidirectional T-source DC Circuit Breaker for DC Microgrids 会议论文
14th IEEE Conference on Industrial Electronics and Applications, ICIEA 2019, 2 Huzhu Road, Xi'an, China, 2019-06-19
作者:  Song, Weizhang;  An, Ning;  Wang, Youyun
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/20
Electronics of Time-of-Flight Measurement for Back-n at CSNS 会议论文
IEEE TRANSACTIONS ON NUCLEAR SCIENCE, 2019-07-01
作者:  Yu, T.;  Cao, P.;  Ji, X. Y.;  Xie, L. K.;  Huang, X. R.
收藏  |  浏览/下载:14/0  |  提交时间:2019/12/30
DEEP LEARNING OF CT/MR IMAGES FOR NON-INVASIVE DETECTION OF CLINICALLY SIGNIFICANT PORTAL HYPERTENSION IN PATIENTS WITH CIRRHOSIS: RESULTS FROM TWO PROSPECTIVE, MULTICENTER COHORTS 会议论文
Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, NOV 08-12, 2019
作者:  Qi, Xiaolong;  Ning, Zhenyuan;  Yu, Qian;  Liu, Yanna, Jr.;  Han, Kangfu
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/31
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:11/0  |  提交时间:2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载:11/0  |  提交时间:2019/11/19


©版权所有 ©2017 CSpace - Powered by CSpace